» Articles » PMID: 15015964

Treatment Advances in Multiple Myeloma

Overview
Journal Br J Haematol
Specialty Hematology
Date 2004 Mar 16
PMID 15015964
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.

Zhao Y, Xie Z, Lin J, Liu P Am J Transl Res. 2017; 9(5):2437-2446.

PMID: 28559994 PMC: 5446526.


CD28-mediated regulation of multiple myeloma cell proliferation and survival.

Bahlis N, King A, Kolonias D, Carlson L, Liu H, Hussein M Blood. 2007; 109(11):5002-10.

PMID: 17311991 PMC: 1885531. DOI: 10.1182/blood-2006-03-012542.


Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery.

Zahlten-Hinguranage A, Goldschmidt H, Cremer F, Egerer G, Moehler T, Witte D Br J Cancer. 2006; 95(7):782-7.

PMID: 16969356 PMC: 2360525. DOI: 10.1038/sj.bjc.6603329.